Cardiovascular Diseases Clinical Trial
To develop genetic maps for the genome-wide screening markers used by multiple investigators and to investigate map differences between sexes and different ethnic groups.
BACKGROUND:
Meiotic linkage maps are the foundation of both linkage and linkage disequilibrium studies
for mapping disease genes. Despite the importance of precise maps, existing genome-wide
linkage maps were built using only a small collection of pedigrees, and so have wide
confidence intervals surrounding estimates of map distance. Incorrect marker order and map
distances can have a profound effect on linkage analyses. Using a sex-averaged map instead of
a sex-specific map biases the lod scores upward, markedly increasing the false positive rate.
Since it is very costly to follow-up many false-positive results, there is a clear need for
more precise and accurate sex-specific genetic maps. Accurate estimates of meiotic map
distance cannot be obtained by any means other than by linkage analysis using genotype data.
The study is in response to a Request for Applications entitled "NHLBI Innovative Research
Grant Program" released in July, 2001. The purpose of the initiative is to support new
approaches to heart, lung, and blood diseases and sleep disorders that use existing data sets
or existing biological specimen collections whether obtained through National Heart, Lung,
and Blood Institute support or not.
DESIGN NARRATIVE:
The genetic epidemiology study will build improved highly-precise sex-specific linkage maps
utilizing thousands of individuals who have previously been genotyped. After filtering out
obvious relationship and genotype errors, the study will incorporate methods that properly
model for genotyping errors. In addition to creating precise maps for the scientific
community, the study will also use these genotype data to study how recombination may vary
between ethnic groups. The genotypes generated by the NHLBI Mammalian Genotyping Service are
precisely the type of data required to produce more accurate maps. These data collections
contain over 3,400 pedigrees with more than a 100-fold increase in information compared to
that contained in the 8 CEPH families that have been used to construct current genome-wide
linkage maps. The new maps will be made publicly available and the genotype data from the
study will be accessible by the MAP-0-MAT linkage mapping server. In the future, the study
will be broadened to incorporate genotype data from additional genotyping centers such as the
Center for Inherited Disease Research (CIDR).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|